CAHP Statement: 2018 Covered California Rate Release
Covered California today announced the final rates for its health plans in 2018 noting that, in the absence of a federal commitment to fund cost-sharing reduction (CSR) reimbursements for the upcoming year, it will be adding an average surcharge of 12.4 percent to Silver-tier plans in 2018. The surcharge will only be applied to Silver-tier plans and, as such, most enrollees' premiums will not be affected by the surcharge.
CAHP Statement: CAHP Applauds Governor Brown’s Signing of Landmark Prescription Drug Price Transparency Bill into Law
The California Association of Health Plans today applauded California Governor Jerry Brown’s signing of the groundbreaking SB 17 (Hernandez) into law. This pivotal moment marks a major victory for patients, healthcare providers and local governments alike in the battle to rein in spiraling prescription drug prices. The Governor’s signature on the bill comes after several years of united efforts from a broad coalition of health plans, labor unions, patient advocacy groups, business organizations and dozens of others, with two similarly-targeted efforts stalling in the legislature in 2015 and 2016.
CAHP Statement: CAHP Urges Congress to Oppose Graham-Cassidy-Heller-Johnson Proposal
The California Association of Health Plans today sent a letter to the California congressional delegation opposing the Graham-Cassidy-Heller-Johnson proposal, which makes major changes to the Affordable Care Act that will result in adverse consequences for Californians and people across the country.
Issue Spotlight: What They’re Saying About The “Health Insurance Tax” (HIT)
Issue Spotlight: What They’re Saying About The “Health Insurance…
CAHP Statement: Senate Approves SB 17, Sends Crucial Rx Transparency Bill to Governor’s Desk for Final Consideration
The California State Senate minutes ago joined the Assembly in voting to advance SB 17 (Hernandez), marking a crucial milestone that will advance the prescription drug price transparency bill to the Governor’s desk. The Senate advanced the bill on a 31-8 vote, a strong showing of support that comes on the heels of the Assembly’s overwhelming 66-9 bipartisan vote to advance the bill on Monday.
CAHP Statement: Assembly Passes SB 17 Marking Major Milestone for Fight to Bring Drug Price Transparency to California
The California State Assembly moments ago passed SB 17 (Hernandez) on a bipartisan 66 – 9 vote, sending the bill to the Senate floor for concurrence before moving on to the Governor’s desk. With today’s passage through the Assembly, California moves closer than ever to holding pharmaceutical companies accountable and reining in arbitrary drug price hikes that harm California families.
Fact Sheet: Bipartisan Support for Drug Price Transparency
Fact Sheet: Bipartisan Support for Drug Price Transparency
Infographic: SB 17: Transparency in Drug Pricing
Infographic: SB 17: Transparency in Drug Pricing
Fact Sheet: Cost-Sharing Reductions (CSRs) Explained
Fact Sheet: Cost-Sharing Reductions (CSRs) Explained
Fact Sheet: Impacts on Individual Health Plan Premiums – 2018
Fact Sheet: Impacts on Individual Health Plan Premiums - 20…
CAHP Fact Sheet: New Health Care Mandates Would Drive Up Premiums By $943 Million
CAHP Fact Sheet: Say No to SB 598: A Prescription for Low-Value Healthcare